Incyte (INCY) Other Working Capital Changes (2010 - 2026)
Incyte's (INCY) quarterly Other Working Capital Changes came in at $14.0 million in Q2 2026, down 83.75% YoY from $86.4 million in Q2 2025, and up 252.75% on a QoQ basis from -$9.2 million in Q1 2026.
Incyte (INCY) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Incyte (INCY) has 17 years of Other Working Capital Changes data on file, last reported at $14.0 million in Q2 2026.
- Quarterly Other Working Capital Changes fell 83.75% year-over-year to $14.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.6 million (down 87.14% YoY) and the FY2025 annual result came in at $156.2 million, up 1607.35% from the prior year.
- Other Working Capital Changes climbed to $14.0 million in Q2 2026, from -$9.2 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $86.4 million in Q2 2025 to a low of -$65.7 million in Q4 2024.
- A 5-year average of $12.4 million and a median of $14.0 million in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes sank 241.42% — and 2025, when it jumped 3554.0%.
- Tracing INCY's Other Working Capital Changes over 5 years: stood at -$9.3 million in 2022, then tumbled by 111.17% to -$19.6 million in 2023, then tumbled by 235.61% to -$65.7 million in 2024, then gained by 1.08% to -$65.0 million in 2025, then jumped by 121.59% to $14.0 million in 2026.
- The last three Other Working Capital Changes figures came in at $14.0 million (Q2 2026), -$9.2 million (Q1 2026), and -$65.0 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Incyte | 24.15 Bn | 19.61 Bn | 1.57 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.04 Mn |
| Jun 30, 2026 | 14.04 Mn |
| Jun 30, 2026 | 14.04 Mn |
| Mar 31, 2026 | -9.19 Mn |
| Mar 31, 2026 | -9.19 Mn |
| Mar 31, 2026 | -9.19 Mn |
| Dec 31, 2025 | -65.04 Mn |
| Dec 31, 2025 | -65.04 Mn |
| Dec 31, 2025 | -65.04 Mn |
| Sep 30, 2025 | 72.84 Mn |
| Sep 30, 2025 | 72.84 Mn |
| Sep 30, 2025 | 72.84 Mn |
| Jun 30, 2025 | 86.40 Mn |
| Jun 30, 2025 | 86.40 Mn |
| Jun 30, 2025 | 86.40 Mn |
| Mar 31, 2025 | 62.05 Mn |
| Mar 31, 2025 | 62.05 Mn |
| Mar 31, 2025 | 62.05 Mn |
| Dec 31, 2024 | -65.75 Mn |
| Dec 31, 2024 | -65.75 Mn |